The Strategist: Beatrix Szebeni-Varga
By
Our Expert on Quality and Regulatory Compliance
New Article in Major Journal Highlights Flaws in American Circumcision Policy
The need for transparency on non-medical factors in circumcision policy.
Healing the Harm, Restoring Wholeness
Insights From Our White Paper
November 1st, 2025
Rat trial results are published! Plus: Final safety testing is nearing completion in the lab
October 1st, 2025
Promising Biocompatibility Results
September 2nd, 2025
Foregen moves towards milestone 4, launches lab tour video, and seeks institutional funding.
June 2nd, 2023
Ethics Review, Research Updates, and Team Resilience
May 2nd, 2023
More Progress with Sheep Trials and HistologiX
Sheep Trials: Successful Blood Vessel Formation and Scaffold Colonization
"It's a Fantastic Thing"
April 2nd, 2023
Roadmap to Animal Trials Completion
March 2nd, 2023
Perfecting technique on sheep
February 1st, 2023
Newsletter
A New Era for Foregen
Improved Governance Structure
Year in Review: 2022
Looking Back
Stakeholder Report #2: Sheep Trials
Animal Trials
.png)
.png)
.png)
.png)
.png)
Commentarium
by foregen